181 related articles for article (PubMed ID: 37341610)
1. Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine Hepaciviruses.
Zhang Y; Kinast V; Sheldon J; Frericks N; Todt D; Zimmer M; Caliskan N; Brown RJP; Steinmann E; Pietschmann T
Microbiol Spectr; 2023 Aug; 11(4):e0128423. PubMed ID: 37341610
[TBL] [Abstract][Full Text] [Related]
2. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
3. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
4. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle.
Kinast V; Plociennikowska A; Anggakusuma ; Bracht T; Todt D; Brown RJP; Boldanova T; Zhang Y; Brüggemann Y; Friesland M; Engelmann M; Vieyres G; Broering R; Vondran FWR; Heim MH; Sitek B; Bartenschlager R; Pietschmann T; Steinmann E
J Hepatol; 2020 Sep; 73(3):549-558. PubMed ID: 32294532
[TBL] [Abstract][Full Text] [Related]
5. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
[TBL] [Abstract][Full Text] [Related]
6. Shiftless Restricts Viral Gene Expression and Influences RNA Granule Formation during Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Rodriguez W; Mehrmann T; Hatfield D; Muller M
J Virol; 2022 Nov; 96(22):e0146922. PubMed ID: 36326276
[TBL] [Abstract][Full Text] [Related]
7. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
9. The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection.
Reinecke B; Frericks N; Lauber C; Dinkelborg K; Matthaei A; Vondran FWR; Behrendt P; Haid S; Brown RJP; Pietschmann T
J Virol; 2022 Apr; 96(7):e0199521. PubMed ID: 35297672
[TBL] [Abstract][Full Text] [Related]
10. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
[TBL] [Abstract][Full Text] [Related]
11. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
[TBL] [Abstract][Full Text] [Related]
13. GB Virus B and Hepatitis C Virus, Distantly Related Hepaciviruses, Share an Entry Factor, Claudin-1.
Toon K; Kalemera MD; Palor M; Rose NJ; Takeuchi Y; Grove J; Mattiuzzo G
J Virol; 2023 Jul; 97(7):e0046923. PubMed ID: 37310242
[TBL] [Abstract][Full Text] [Related]
14. Identification of rodent homologs of hepatitis C virus and pegiviruses.
Kapoor A; Simmonds P; Scheel TK; Hjelle B; Cullen JM; Burbelo PD; Chauhan LV; Duraisamy R; Sanchez Leon M; Jain K; Vandegrift KJ; Calisher CH; Rice CM; Lipkin WI
mBio; 2013 Apr; 4(2):e00216-13. PubMed ID: 23572554
[TBL] [Abstract][Full Text] [Related]
15. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.
Frericks N; Brown RJP; Reinecke BM; Herrmann M; Brüggemann Y; Todt D; Miskey C; Vondran FWR; Steinmann E; Pietschmann T; Sheldon J
J Virol; 2024 Mar; 98(3):e0192123. PubMed ID: 38319104
[TBL] [Abstract][Full Text] [Related]
17. Viral persistence, liver disease, and host response in a hepatitis C-like virus rat model.
Trivedi S; Murthy S; Sharma H; Hartlage AS; Kumar A; Gadi SV; Simmonds P; Chauhan LV; Scheel TKH; Billerbeck E; Burbelo PD; Rice CM; Lipkin WI; Vandegrift K; Cullen JM; Kapoor A
Hepatology; 2018 Aug; 68(2):435-448. PubMed ID: 28859226
[TBL] [Abstract][Full Text] [Related]
18. Two methods of heterokaryon formation to discover HCV restriction factors.
Frentzen A; Hueging K; Bitzegeio J; Pietschmann T; Steinmann E
J Vis Exp; 2012 Jul; (65):e4029. PubMed ID: 22825033
[TBL] [Abstract][Full Text] [Related]
19. Restriction of Flaviviruses by an Interferon-Stimulated Gene SHFL/C19orf66.
Suzuki Y; Murakawa T
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293480
[TBL] [Abstract][Full Text] [Related]
20. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
